Stay updated on KX2-361 Safety & PK in Refractory Malignancies Clinical Trial

Sign up to get notified when there's something new on the KX2-361 Safety & PK in Refractory Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KX2-361 Safety & PK in Refractory Malignancies Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0 while the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:34:18.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A banner announces that NIH is transitioning to use “Super Intelligence” instead of “Artificial Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T16:07:33.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.1 to v3.7.2 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T20:38:33.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T20:31:10.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the study details. The visible content is limited to the error message and site footer, indicating access is blocked.
    Difference
    16%
    Check dated 2026-09-20T20:47:27.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Revision: v3.6.6 is now displayed in place of Revision: v3.6.5, indicating a minor platform update. No study data or user-facing content is modified.
    Difference
    0.1%
    Check dated 2026-08-30T21:49:31.000Z thumbnail image

Stay in the know with updates to KX2-361 Safety & PK in Refractory Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KX2-361 Safety & PK in Refractory Malignancies Clinical Trial page.